# Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

> **NCT04050540** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 449 (actual)

## Conditions studied

- HIV Infections
- HIV/AIDS
- Neisseria Gonorrheae Infection
- Chlamydia Trachomatis Infection
- Syphilis Infection

## Interventions

- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT04050540
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-05
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2024-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050540, "Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04050540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*